• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    CMS Establishes New Payment for Pelvalon’s Eclipse System

    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy

    Resonetics Leases New Manufacturing Space in Costa Rica

    Seisa Medical Acquires ProtoQuick and Peridot

    Masimo Device is Useful in Assessing Respiratory Status of Pediatric Tracheostomy Patients
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Transporting Treatment: An Examination of Tubing Technologies

    Outward Appearance: Reviewing Surface Treatment Options

    Face to (Virtual) Face: Telemedicine Now and Post-Pandemic

    Voices for Medtech: AdvaMed and MDMA Leaders Share Thoughts

    Digitize Your QMS via an Enterprise Cloud Platform
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Home Is Where the Heart (Valve) Is

    CGM: Digital Health Meets a Very Large Opportunity

    Biomechanical Engineer, Heal Thyself

    Optimizing MIM in Medical Device Manufacturing

    PPE and Diagnostics: Sourcing Domestically and Speeding Time to Market
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    MW Life Sciences

    Medbio LLC

    Forefront Medical Technology

    Medicoil

    Spectrum Plastics Group
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Three Future Trends and Opportunities in Quality Assurance

    Adopting a Data-Driven Quality Model

    Digital Transformation for Quality and Manufacturing

    Digging into the Cardiac Arrhythmia Monitoring Device Market

    EMS Providers Supplying More Than Electronics to Customers
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Medbio LLC

    maxon

    MW Life Sciences

    K-Tube Technologies

    Concise Engineering
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Ortho Clinical Diagnostics, Quest to Broaden Availability of COVID-19 Antibody Testing

    Quest will use Ortho’s IgG antibody test to test 3 million patients per month for coronavirus antibodies.

    Related CONTENT
    • Cardiovascular Device Market Expands to Tackle Higher Disease Burden
    • Global Supply Chain Wisdom from Coronavirus-Colored Lenses
    • Diagnosing the IVD Market: An Interview with TEAM Technologies
    • Ultrasound Stimulation Can Reduce Obesity, Research Indicates
    • Harnessing Critical Health Data With Wearable Technology
    Ortho Clinical Diagnostics05.12.20
    Ortho Clinical Diagnostics, a global developer of in-vitro diagnostics with a history of bringing critical tests for infectious diseases to market, is working with Quest Diagnostics, a provider of diagnostic information services, to expand COVID-19 antibody testing to more than 20 Quest laboratories across the United States.
     
    Quest will use Ortho’s VITROS Immunodiagnostic Products Anti-SARS-CoV-2 IgG Test (COVID-19 IgG antibody test) to test patients for detectable levels of SARS-CoV-2 antibodies, which are generated by the body in response to infection. Ortho’s test, among only a small number in the world to be granted Emergency Use Authorization by the U.S. Food and Drug Administration (FDA), can be used as an aid in identifying patients with an immune response, indicating recent or prior infection, and may provide helpful information regarding decisions for getting people back to work. Individuals may have the virus for weeks after developing antibodies. The test offers 100 percent specificity, which helps prevent false positives.  

    “Together with Quest, Ortho Clinical Diagnostics is pleased to make available a high quality, large-scale COVID-19 testing solution to quickly reach millions of Americans,” said Michael S. Iskra, president, North America Commercial Operations, Ortho Clinical Diagnostics. “One hundred percent specificity highlights the accuracy of Ortho’s antibody test. In this widespread health crisis, Ortho strongly believes that every test is a life and is proud to join with Quest in the fight against coronavirus.”
     
    “Antibody testing can play an important role in helping individuals understand if they’ve been exposed to the virus that causes COVID-19 and may have mounted an immune response,” said Jay G. Wohlgemuth, M.D., senior vice president and chief medical officer for Quest Diagnostics. “Through our relationship with Ortho Clinical Diagnostics, we are broadening the range of high quality COVID-19 antibody test platforms we use in our laboratories to serve growing demand.”
     
    Quest offers two ways to access COVID-19 antibody testing. Healthcare providers can order testing on behalf of their patients, or individuals can initiate physician-directed testing online, without visiting a doctor's office, through QuestDirect.
     
    Ortho currently offers two COVID-19 antibody tests. Ortho’s total antibody test, granted Emergency Use Authorization on April 14, detects all COVID-19 related antibodies, including IgM, which appears in the early, acute stage of infection, and helps determine the onset of a patient’s immune response by monitoring all antibodies generated through disease progression. Ortho’s COVID-19 IgG test, granted Emergency Use Authorization on April 24, detects only the IgG antibody which appears in a patient’s blood in the later phase of the infection and remains elevated even after recovery.
     
    Both of Ortho’s tests help health care professionals understand if a patient has been exposed to and has developed antibodies to the SARS-CoV-2 virus.
     
    The tests run on Ortho’s high-throughput, fully automated analyzers including its flagship VITROS XT 7600 Integrated System, the VITROS 3600 Immunodiagnostic System, the VITROS 5600 Integrated System and will soon be available on VITROS ECi/ECiQ Immunodiagnostic Systems. VITROS Systems, already installed in more than 1,000 hospitals and reference labs in the United States, are self-contained and do not require an external water source to run, offering labs placement flexibility.
     
    Ortho began shipping its antibody tests weeks ago to hotspot areas with highest priority and continues to ramp up its production. Ortho plans to manufacture several million COVID-19 IgG antibody tests each month for Quest Diagnostics and other laboratory providers.
     
    Ortho’s COVID-19 IgG antibody tests are designed and solely intended to be performed by laboratory professionals and cannot be directly used by patients as they are not for home use. The VITROS Anti-SARS-CoV-2 Total and IgG tests have not been cleared by the FDA. They have been authorized by the FDA under an emergency use authorization and testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform moderate or high complexity tests. The VITROS Antibody tests have been authorized only for the detection of either total or IgG antibodies from SARS-CoV-2, not for any other viruses or pathogens, and results should not be used as the sole basis for diagnosis. These tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in-vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
     
    Related Searches
    • Diagnostics
    Related Knowledge Center
    • Diagnostics
    Suggested For You
    Cardiovascular Device Market Expands to Tackle Higher Disease Burden Cardiovascular Device Market Expands to Tackle Higher Disease Burden
    Global Supply Chain Wisdom from Coronavirus-Colored Lenses Global Supply Chain Wisdom from Coronavirus-Colored Lenses
    Diagnosing the IVD Market: An Interview with TEAM Technologies Diagnosing the IVD Market: An Interview with TEAM Technologies
    Ultrasound Stimulation Can Reduce Obesity, Research Indicates Ultrasound Stimulation Can Reduce Obesity, Research Indicates
    Harnessing Critical Health Data With Wearable Technology Harnessing Critical Health Data With Wearable Technology
    GE Healthcare Reveals Vscan Air Wireless, Handheld Ultrasound GE Healthcare Reveals Vscan Air Wireless, Handheld Ultrasound
    Solid Growth Forecast for Japan Solid Growth Forecast for Japan's MI Neurosurgical Devices Market
    South Korean HIV Testing to Reach Peak Market Value This Year South Korean HIV Testing to Reach Peak Market Value This Year
    Quidel Opens New Manufacturing Facility to Boost COVID-19 Antigen Test Production Quidel Opens New Manufacturing Facility to Boost COVID-19 Antigen Test Production
    4 Trends Driving Medical Manufacturing in 2021 4 Trends Driving Medical Manufacturing in 2021
    Pioneering AI Solutions to Reinforce Healthcare Services Pioneering AI Solutions to Reinforce Healthcare Services
    BD Earns EUA, CE Mark for Combo SARS-CoV-2, Influenza A+B Test BD Earns EUA, CE Mark for Combo SARS-CoV-2, Influenza A+B Test
    Cybersecurity Measures are Crucial as COVID-19 Drives Adoption of Remote Access Devices Cybersecurity Measures are Crucial as COVID-19 Drives Adoption of Remote Access Devices
    Evolving Trends in the Medical and Orthopedic Devices Industry Evolving Trends in the Medical and Orthopedic Devices Industry
    Report: Emergency Use Authorization a Top Health Hazard for 2021 Report: Emergency Use Authorization a Top Health Hazard for 2021

    Related Breaking News

    • Diagnostics
      Hologic to Buy Mobidiag for $795M

      Hologic to Buy Mobidiag for $795M

      Hologic gains near-patient, acute care diagnostic testing platforms.
      Sam Brusco, Associate Editor 04.08.21

    • Diagnostics
      EKF Launches STAT-Site WB β-Ketone and Glucose Handheld Analyzer

      EKF Launches STAT-Site WB β-Ketone and Glucose Handheld Analyzer

      Company obtains CE mark certification alongside CLIA waiver for easy-to-use whole blood analyzer for diabetes care programs.
      Michael Barbella, Managing Editor 04.07.21

    • Diagnostics
       BD Gains EUA for Asymptomatic COVID-19 Screening via Rapid Testing

      BD Gains EUA for Asymptomatic COVID-19 Screening via Rapid Testing

      BD Veritor Plus System supports return-to-school and return-to-work programs through serial testing.
      Sam Brusco, Associate Editor 04.01.21


    • Diagnostics
      Abbott

      Abbott's Rapid COVID-19 Self-Test Receives EUA

      Permits asymptomatic, non-prescription, over-the-counter self-use for people with or without symptoms.
      Sam Brusco, Associate Editor 04.01.21

    • Diagnostics
      BD

      BD's Combo COVID-19, Flu Rapid Antigen Test Earns EUA

      Can detect SARS-CoV-2, influenza A, influenza B from a single patient sample in 15 minutes.
      Sam Brusco, Associate Editor 03.30.21

    • Diagnostics
      FDA OKs GE Healthcare

      FDA OKs GE Healthcare's New 3D Surgical Imaging System

      OEC 3D brings precise 3D and 2D imaging to surgical suites, improving efficiency.
      Sam Brusco, Associate Editor 03.25.21


    • Diagnostics
      Optellum Receives FDA Clearance for Virtual Nodule Clinic

      Optellum Receives FDA Clearance for Virtual Nodule Clinic

      Empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is now commercially available in the U.S.
      Charles Sternberg, Assistant Editor 03.23.21

    • Diagnostics
      FDA Authorizes Machine Learning-Based COVID-19 Biomarker Screening Device

      FDA Authorizes Machine Learning-Based COVID-19 Biomarker Screening Device

      Identifies biomarkers that may be indicative of SARS-CoV-2 infection as well as other hypercoagulable conditions.
      Sam Brusco, Associate Editor 03.23.21

    • Diagnostics
      GE Healthcare Reveals Vscan Air Wireless, Handheld Ultrasound

      GE Healthcare Reveals Vscan Air Wireless, Handheld Ultrasound

      Touts dual-probe whole-body scanning capabilities.
      Sam Brusco, Associate Editor 03.17.21


    • Diagnostics
      FDA OKs Olympus

      FDA OKs Olympus' Narrow Band Imaging to Assess Colonic Lesions

      New evidence supports NBI to characterize polyps found during screening colonoscopies for colorectal cancer.
      Sam Brusco, Associate Editor 03.16.21

    • Diagnostics
      Roche to Acquire GenMark Diagnostics for $1.8B

      Roche to Acquire GenMark Diagnostics for $1.8B

      GenMark’s syndromic panel testing portfolio complements Roche’s current molecular diagnostics portfolio.
      Sam Brusco, Associate Editor 03.15.21

    • Diagnostics
      FDA Issues EUA to First OTC Home Molecular COVID-19 Test

      FDA Issues EUA to First OTC Home Molecular COVID-19 Test

      Results from the Cue COVID-19 test are sent directly to a companion app in about 20 minutes.
      Sam Brusco, Associate Editor 03.08.21


    • Diagnostics
      Avacta’s Rapid Antigen Test Proves Effective for New Coronavirus Variants

      Avacta’s Rapid Antigen Test Proves Effective for New Coronavirus Variants

      Detects the B117, or ‘Kent’, variant, and the D614G variant, as well as the original strain.
      Charles Sternberg, Assistant Editor 03.08.21

    • Diagnostics
      EUA Granted for New COVID-19, Flu A, Flu B Combo Kit

      EUA Granted for New COVID-19, Flu A, Flu B Combo Kit

      One multiplex real-time PCR diagnostic kit can simultaneously detect and differentiate SARS-CoV-2, influenza A and influenza B.
      Michael Barbella, Managing Editor 03.05.21

    • Diagnostics
      EchoNous Expands Its Kosmos Hardware Platform

      EchoNous Expands Its Kosmos Hardware Platform

      Adds continuous wave and pulsed wave Doppler capabilities.
      Charles Sternberg, Assistant Editor 03.04.21


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Cheetah Medical Introduces Noninvasive Monitoring System
    • Face Mask Filters 98 Percent Of COVID-19 Particles
    • Diagnosing The IVD Market: An Interview With TEAM Technologies
    • Top 10 Trends In The Medical Device And Equipment Industry
    Breaking News
    • CMS Establishes New Payment for Pelvalon’s Eclipse System
    • Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    • Resonetics Leases New Manufacturing Space in Costa Rica
    • Seisa Medical Acquires ProtoQuick and Peridot
    • Masimo Device is Useful in Assessing Respiratory Status of Pediatric Tracheostomy Patients
    View Breaking News >
    CURRENT ISSUE

    April 2021

    • Transporting Treatment: An Examination of Tubing Technologies
    • Face to (Virtual) Face: Telemedicine Now and Post-Pandemic
    • Outward Appearance: Reviewing Surface Treatment Options
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Kyowa Hakko Launches Heat-Treated Probiotic Strain for Eye Health
    CGA-7 Green Coffee Extract by Vidya Herbs Achieves Self-Affirmed GRAS Status
    Nutritional Complex Evidenced to Reduce Preterm Birth
    Coatings World

    Latest Breaking News From Coatings World

    Barentz Expands Canadian CASE Team
    Shepherd Color Company Opens Sales Office in China
    Chromaflo Technologies Awarded Gold Status CSR Rating by EcoVadis in EMEA
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    CMS Establishes New Payment for Pelvalon’s Eclipse System
    Varian, Google Cloud Partner to Bring Convenience to Cancer Therapy
    Resonetics Leases New Manufacturing Space in Costa Rica
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
    Ascendia Pharmaceuticals Poised for Expansion
    Bora Pharmaceuticals Adds Roller Compaction Capabilities
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Revlon Unveils New Fragrances Featuring Megan Thee Stallion & Sofia Carson
    Henkel Management Board Welcomes Wolfgang König
    Mielle Organics Gets a Major Investment
    Happi

    Latest Breaking News From Happi

    Nature’s Beauty Debuts Vegan Natural Body Care at Walgreens
    Estée Lauder Expands Beautiful Fragrance Collection
    What You’re Reading on Happi.com
    Ink World

    Latest Breaking News From Ink World

    SE-DA Invests in Kornit Presto S
    Kumon North America Adds Speedmaster XL 106 from Heidelberg
    Iron Oxide Pigments Market to Register 4.7% CAGR from 2021 to 2028: GVR
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Dantex elevates Joseph Sanchez to digital business development manager
    Mactac's Kevin Clunie joins TLMI panel
    MacDermid announces two new global sales roles
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Precision Textiles Offers Biodegradable Medical Fabric
    Northshore Launches Megamax Briefs in New Colors
    Essity Acquires Distribution Rights to Sorbact in Australia and New Zealand
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    New Biosealant Could Stabilize Cartilage, Boost Healing After Injury
    Google Executive Joins SeaSpine's Board of Directors
    HSS and LimaCorporate Open Provider-Based 3D Design and Printing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Tive Multi-sensor Tracker Solo 5G Relies on Sensirion SHT33
    VTT in 2020: Successful Year Despite Globally Challenging Times
    Lux Research: 3D Printing Market to Reach $51 Billion in 2030

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login